Details Drug Name: Semaglutide (Wegovy) Category: GLP-1 receptor agonist (antidiabetic medication) International Brand: Wegovy Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg Packaging: Single-use, pre-filled pens 4 pens per pack (4-week supply) Dosage Form: Subcutaneous injection Uses: Long-term weight management in adults with obesity Weight reduction in overweight adults with comorbidities such as hypertension or type 2 diabetes Obesity treatment in adolescents aged 12 and above Reduces risk of major cardiovascular events in patients with obesity and heart disease Supports appetite control and calorie intake regulation How It Works: Wegovy is formulated with semaglutide, a compound that replicates the effects of the bodys natural GLP-1 hormone
The 1.3% gap between pill and injection is unlikely to be clinically meaningful for most people
What if Ive already had a butt lift and I use Ozempic
Other important adverse effects include: Acute pancreatitis : Severe, persistent abdominal pain radiating to the back requires immediate medical attention
Yi X, Abas R, Raja Muhammad Rooshdi RAW, Yan J, Liu C, An J, et al